Annals of internal medicine
-
Comment Randomized Controlled Trial Multicenter Study
In patients at high risk for RA, abatacept reduced inflammation and RA development at 6 mo.
Rech J, Tascilar K, Hagen M, et al. Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial. Lancet. 2024;403:850-859. 38364841.
-
Concern about side effects is a common reason for SARS-CoV-2 vaccine hesitancy. ⋯ National Institute on Aging.
-
Definitions of long COVID are evolving, and optimal models of care are uncertain. ⋯ Agency for Healthcare Research and Quality. (Protocol posted at https://effectivehealthcare.ahrq.gov/products/long-covid-models-care/protocol.).
-
In patients with advanced chronic kidney disease (CKD), the effects of initiating treatment with an angiotensin-converting enzyme inhibitor (ACEi) or angiotensin-receptor blocker (ARB) on the risk for kidney failure with replacement therapy (KFRT) and death remain unclear. ⋯ National Institutes of Health. (PROSPERO: CRD42022307589).